[Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience].
Impacto de la COVID-19 en el tratamiento del infarto agudo de miocardio con elevación del segmento ST. La experiencia española.
COVID-19
Primary angioplasty
STEMI
STEMI network
Journal
Revista espanola de cardiologia
ISSN: 1579-2242
Titre abrégé: Rev Esp Cardiol
Pays: Spain
ID NLM: 0404277
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
29
05
2020
accepted:
28
07
2020
pubmed:
20
10
2020
medline:
20
10
2020
entrez:
19
10
2020
Statut:
ppublish
Résumé
The COVID-19 outbreak has had an unclear impact on the treatment and outcomes of patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess changes in STEMI management during the COVID-19 outbreak. Using a multicenter, nationwide, retrospective, observational registry of consecutive patients who were managed in 75 specific STEMI care centers in Spain, we compared patient and procedural characteristics and in-hospital outcomes in 2 different cohorts with 30-day follow-up according to whether the patients had been treated before or after COVID-19. Suspected STEMI patients treated in STEMI networks decreased by 27.6% and patients with confirmed STEMI fell from 1305 to 1009 (22.7%). There were no differences in reperfusion strategy (> 94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, The number of STEMI patients treated during the current COVID-19 outbreak fell vs the previous year and there was an increase in the median time from symptom onset to reperfusion and a significant 2-fold increase in the rate of in-hospital mortality. No changes in reperfusion strategy were detected, with primary percutaneous coronary intervention performed for the vast majority of patients. The co-existence of STEMI and SARS-CoV-2 infection was relatively infrequent.
Identifiants
pubmed: 33071427
doi: 10.1016/j.recesp.2020.07.033
pii: S0300-8932(20)30474-7
pmc: PMC7546233
doi:
Types de publication
English Abstract
Journal Article
Langues
spa
Pagination
994-1002Informations de copyright
© 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.
Références
Circ Cardiovasc Interv. 2019 Jan;12(1):e007081
pubmed: 30608874
BMC Infect Dis. 2010 May 28;10:139
pubmed: 20509887
Eur Heart J. 2020 May 14;41(19):1791-1794
pubmed: 32232396
Med Care. 2014 Apr;52(4):336-45
pubmed: 24556894
Circulation. 2004 Mar 16;109(10):1223-5
pubmed: 15007008
JACC Case Rep. 2020 Aug;2(10):1620-1624
pubmed: 32835261
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
Rev Esp Cardiol (Engl Ed). 2019 Dec;72(12):1043-1053
pubmed: 31732434
Circulation. 2003 May 27;107(20):2577-82
pubmed: 12732606
Am J Cardiol. 2007 Jun 15;99(12):1680-6
pubmed: 17560875
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Circulation. 2020 Jun 23;141(25):2113-2116
pubmed: 32352306
Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):778-780
pubmed: 32565077
N Engl J Med. 2020 Jun 18;382(25):2478-2480
pubmed: 32302081
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
Circulation. 2011 Jan 4;123(1):46-52
pubmed: 21173352
Eur Heart J Acute Cardiovasc Care. 2019 Aug;8(5):443-456
pubmed: 31172789
J Am Coll Cardiol. 2020 May 12;75(18):2372-2375
pubmed: 32199938
Am J Emerg Med. 2020 Jun 6;:
pubmed: 32540217